ESSA Pharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $135 |
Gross Profit | -16 | -24 | -23 | 67 |
EBITDA | -4,979 | -6,350 | -8,508 | -6,332 |
EBIT | -4,996 | -6,374 | -9,917 | -6,355 |
Net Income | -4,003 | -6,374 | -8,531 | -6,355 |
Net Change In Cash | 0 | 0 | 0 | 135 |
Free Cash Flow | -4,200 | -6,848 | -6,470 | -3,366 |
Cash | 85,952 | 86,308 | 93,310 | 103,709 |
Basic Shares | 44,388 | 44,388 | 44,366 | 44,366 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -90 | -118 | -121 | -109 |
EBITDA | -28,452 | -26,455 | -35,079 | -36,708 |
EBIT | -28,542 | -26,573 | -35,201 | -36,817 |
Net Income | -28,542 | -26,582 | -35,103 | -36,805 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -22,716 | -19,781 | -28,704 | -25,415 |
Cash | 103,709 | 33,701 | 57,076 | 137,825 |
Basic Shares | 44,277 | 44,089 | 44,038 | 38,480 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.09 |
2025-03-31 | -$0.14 |
2024-12-31 | -$0.27 |
